PMCA. A decade of in vitro prion replication

Current Chemical Biology

Volumn 4, Issue 3, 2010, Pages 200-207

  Fernández Borges, Natalia ^a   Castilla, Joaquín ^a,b  

^a CIC BIOGUNE   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

In vitro replication; PMCA; Prion; Scrapie; Transmissible Spongiform Encephalopathy (TSE)

Indexed keywords

ARTICLE; GENE AMPLIFICATION; IN VITRO STUDY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; VIRUS DETECTION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; MAMMALIA;

EID: 78649314201     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231310792062693     Document Type: Article

References (56)

1. Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370: 471-4.
2. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411: 810-13
3. Soto C, Saborio GP. Prions: disease propagation and disease therapy by conformational transmission. Trends Mol Med 2001; 7: 109-14
4. Saá P, Castilla J, Soto C. Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol 2005; 299: 53-65
5. Castilla J, Saá P, Hetz C, et al. In vitro generation of infectious scrapie prions. Cell 2005; 121: 195-206
6. Castilla J, Saá P, Morales R, et al. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412: 3-21
7. Saá P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 2006; 281: 35245-52
8. Kim JI, Cali I, Surewicz K, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian co-factors. J Biol Chem 2010; 285: 14083-7
9. Deleault NR, Harris BT, Rees JR, et al. From the Cover: Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104: 9741-6
10. Wang F, Wang X, Yuan CG, et al. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327: 1132-5
11. Murayama Y, Yoshioka M, Yokoyama T, et al. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci Lett 2006; 413: 270-3
12. Shi S, Dong CF, Tian C, et al. The propagation of hamster-adapted scrapie PrPSc can be enhanced by reduced pyridine nucleotide in vitro. FEBS J 2009; 276: 1536-45
13. Richt JA, Kasinathan P, Hamir AN, et al. Production of cattle lacking prion protein. Nat Biotechnol 2006; 25: 132-8
14. Shi S, Dong CF, Wang GR, et al. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification. Virus Res 2009; 141: 26-33
15. Jones M, Peden A, Prowse C, et al. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrP(Sc). J Pathol 2007; 213: 21-6
16. Jones M, Peden AH, Yull H, et al. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 2008; 49: 376-84
17. Castilla J, Gutiérrez AA, Brun A, et al. Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol 2003; 148: 677-91
18. Mays CE, Titlow W, Seward T, et al. Enhancement of protein misfolding cyclic amplification by using concentrated cellular prion protein source. Biochem Biophys Res Commun 2009; 388(2): 306-10
19. Atarashi R, Moore RA, Sim VL, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4: 645-50
20. Castilla J, Saá P, Soto C. Detection of prions in blood. Nat Med 2005; 11: 982-5
21. Saá P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006; 313: 92-4
22. Thorne L, Terry LA. In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 2008; 89: 3177-84
23. Tattum MH, Jones S, Pal S, et al. Discrimination between prion infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 2010; 50: 996-1002
24. Murayama Y, Yoshioka M, Okada H, et al. Urinary excretion and blood level of prions in scrapie-infected hamsters. J Gen Virol 2007; 88: 2890-8
25. Haley NJ, Seelig DM, Zabel MD, et al. Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS ONE 2009; 4: e4848
26. Haley NJ, Mathiason CK, Zabel MD, et al. Detection of sub clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer. PLoS ONE 2009; 4: e7990
27. Kruger D, Thomzig A, Lenz G, et al. Faecal shedding, alimentary clearance and intestinal spread of prions in hamsters fed with scrapie. Vet Res 2009; 40: 4
28. Maddison BC, Baker CA, Rees HC, et al. Prions are secreted in milk from clinically normal scrapie-exposed sheep. J Virol 2009; 83: 8293-6
29. Seidel B, Thomzig A, Buschmann A, et al. Scrapie Agent (Strain 263K) Can Transmit Disease via the Oral Route after Persistence in Soil over Years. PLoS ONE 2007; 2: e435
30. Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med 2004; 10 (Suppl): S63-S67
31. Nishina K, Deleault NR, Lucassen RW, et al. In vitro prion protein conversion in detergent-solubilized membranes. Biochemistry 2004; 43: 2613-21
32. Kim NH, Choi JK, Jeong BH, et al. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J 2005; 19: 783-5
33. Lucassen R, Nishina K, Supattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 2003; 42: 4127-35
34. Deleault NR, Geoghegan JC, Nishina K, et al. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 2005; 280: 26873-9
35. Tuzi NL, Cancellotti E, Baybutt H, et al. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol 2008; 6: e100
36. Nishina KA, Deleault NR, Mahal SP, et al. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 2006; 45: 14129-39
37. Orru CD, Wilham JM, Hughson AG, et al. Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 2009; 22: 515-21
38. Smirnovas V, Kim JI, Lu X, et al. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by H/D exchange. J Biol Chem 2009; 284: 24233-41
39. Kim JI, Surewicz K, Gambetti P, et al. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. FEBS Lett 2009; 583: 3671-5
40. Weber P, Giese A, Piening N, et al. Generation of genuine prion infectivity by serial PMCA. Vet Microbiol 2007; 123: 346-57
41. Castilla J, Morales R, Saá P, et al. Cell-free propagation of prion strains. EMBO J 2008; 27: 2557-66
42. Fernandez-Borges N, de CJ, Castilla J. In vitro studies of the transmission barrier. Prion 2009; 3: 220-3
43. Green KM, Castilla J, Seward TS, et al. Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 2008; 4: e1000139
44. Kurt TD, Perrott MR, Wilusz CJ, et al. Efficient in vitro amplification of chronic wasting diseasse. Pr Pres J Virol 2007; 81: 9605-8
45. Soto C, Anderes L, Suardi S, et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005; 579: 638-42
46. Castilla J, Gonzalez-Romero D, Saá P, et al. Crossing the species barrier by PrPSc replication in vitro generates unique infectious prions. Cell 2008; 134: 757-68
47. Race R, Chesebro B. Scrapie infectivity found in resistant species. Nature 1998; 392: 770
48. Kurt TD, Telling GC, Zabel MD, et al. Trans-species amplification of PrP(CWD) and correlation with rigid loop 170N. Virology 2009; 387: 235-43
49. Barlow RM. Transmissible mink encephalopathy: pathogenesis and nature of the aetiological agent. J Clin Pathol Suppl (R Coll Pathol) 1972; 6: 102-9
50. Legname G, Baskakov IV, Nguyen HO, et al. Synthetic mammalian prions. Science 2004; 305: 673-6
51. Makarava N, Kovacs GG, Bocharova O, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 2010; 119: 177-87
52. Barria MA, Mukherjee A, Gonzalez-Romero D, et al. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 2009; 5: e1000421
53. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318: 930-6
54. Suyama K, Yoshioka M, Akagawa M, et al. Assessment of prion inactivation by fenton reaction using protein misfolding cyclic amplification and bioassay. Biosci Biotechnol Biochem 2007; 71: 2069-71
55. Morales R, Buytaert-Hoefen KA, Gonzalez-Romero D, et al. Reduction of prion infectivity in packed red blood cells. Biochem Biophys Res Commun 2008; 377: 373-8
56. Geoghegan JC, Miller MB, Kwak AH, et al. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5: e1000535.